跳至主要内容
临床试验/ITMCTR1900002706
ITMCTR1900002706尚未招募未知

A multicenter clinical study for Xiaoke formula based on PTP1B inhibition in the treatment of refractory type 2 diabetes mellitus

Yueyang Hospital of integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Aged 18-75 years male and female;
  • 2. type 2 diabetes patients who meet the diagnostic criteria of Western medicine for diabetes; those who meet the syndrome of deficiency of both qi and Yin in traditional Chinese medicine;
  • 3. those who use insulin (> 0.6 IU/kg) and metformin as the basic treatment, combined with one or two other hypoglycemic drugs, and the dosage is stable, no less than 4 weeks;
  • 4. those who have poor blood glucose control: Blood FPG 7.5 to 10.0 mmol/l; HbA1c 7 to 10.0% (subject to the test value of each center);
  • 5. the subject is informed and signs the informed consent voluntarily.

排除标准

  • 1. Gestational diabetes mellitus, type 1 diabetes mellitus and other special types of diabetes mellitus;
  • 2. patients with acute complications of diabetes mellitus;
  • 3. patients with serious cardiovascular and cerebrovascular diseases and serious primary diseases such as liver, kidney and hematopoietic system;
  • 4. those who are allergic to the known ingredients of the study drug and whose constitution is allergic;
  • 5. pregnant and lactating women and those who have recently had fertility plans;
  • 6. those who have long-term alcohol, drug dependence and mental illness Patients with disease;
  • 7. patients treated with traditional Chinese medicine or proprietary Chinese medicine with oral hypoglycemic purpose within one month before screening;
  • 8. those who participated in or are participating in clinical trials of other drugs within one month before the screening period of this study;
  • 9. researchers think that they are not suitable to participate in this clinical study.

研究者

发起方
Yueyang Hospital of integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine

相似试验